The FDA approves AZN's sBLA seeking the expanded use of Imfinzi for adult patients with muscle-invasive bladder cancer.

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab) perioperative regimen has been approved by the US Food and Drug ...

AstraZeneca’s Imfinzi receives US FDA approval for patients with muscle-invasive bladder cancer: Cambridge, UK Tuesday, April 1, 2025, 10:00 Hrs [IST] AstraZeneca’s Imfinzi (d ...

While March may be winding down, endometriosis is a pressing concern, particularly for the estimated 10 percent of women of ...

The most common sign of menopause flooding is excessive, uncontrollable bleeding. This level of blood loss can also lead to ...

LetsGetChecked, a global leader in healthcare technology solutions, today announced the launch of its comprehensive hereditary cancer solution. Designed to optimize patient care, this solution ...

The health service invites eligible individuals aged between 25 and 64 for cervix screenings every couple of years ...

Trump's federal funding cuts are shutting down studies on Alzheimer’s care, uterine fibroids and pregnancy risks — all ...

A significant study detailing OncoSeek®'s efficacy was published in eClinicalMedicine, a clinical journal of The Lancet, titled A panel o ...

The safety of hair products commonly used by Black women, such as chemical relaxers and hair dyes, has raised concerns due to ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...